Resurgence of COVID-19 cases serious concern: Centre
‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
A vaccine only for Omicron: Does India really need it?
Experts bat for considering benefits, economics carefully before spending on bivalent shots
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
Rwanda: 8 health workers arrested for stealing COVID-19 vaccines, test kits
The accused are employees of 4 health facilities in the country’s western and southern provinces
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
G20 Summit: 7 COVID-19 deaths every minute, rich countries urged to share soon-expiring vaccines
By the end of October, US, EU, Britain and Canada would have a stock of 240 million unused vaccines
COVID-19: Vaccine export to resume from next month, says Mandaviya
More than 300 million doses will be produced in October and more than a billion in the next quarter, according to Mansukh Mandaviya
Serum Institute’s COVID-19 vaccine up for emergency approval
Civil society organisations urge Indian drug regulator to put vaccine trial data in public domain
Cervical cancer: 90% deaths in low and middle income countries with least access to HPV vaccine, screening
These countries also have low rates of vaccination against HPV
India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez
India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …
How ‘vaccine nationalism’ could block vulnerable populations’ access to COVID-19 vaccines
Vaccine nationalism also runs against the fundamental principles of vaccine development and global public health
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Nigeria becomes second country to approve Oxford’s malaria vaccine
After Ghana, Nigeria’s approval of malaria vaccine will help world achieve WHO goal of reducing malaria cases, deaths by 90% by 2030
COVID-19: First few peer reviewed studies suggest vaccine induced antibodies fail to protect from Omicron
The studies, published in Nature, covered Oxford-AstraZeneca vaccine, but not India’s indigenous Covaxin
The COVID-19 pandemic year: Who gained, who lost in health sector during lockdown
A five-part series as India marks a year of the dreaded COVID-19 lockdown: We look at healthcare in this part.
Vaccine Watch: European Union gives emergency approval to Moderna COVID-19 vaccine
The vaccine makes use of the mRNA platform like Pfizer’s vaccine, which the EU has already approved for emergency use
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
COVID-19 vaccines: A mad scramble
Inequitable distribution amid acute shortage has derailed the global vaccination drive against COVID-19. We need to act fast to win the race …
Charging Indians for COVID-19 vaccines is bad, letting vaccine producers charge what they like is unconscionable
Most other nations, including Australia, the US, UK, Germany, France and China, are providing vaccines free of cost to all.
COVID-19 vaccines: India’s 2021 challenge
India has enhanced its global standing by supplying COVID-19 vaccines to rich and poor countries alike. It must now scale up its manufacturing by …
The cold supply chain can’t reach everywhere — that’s a big problem for equitable COVID-19 vaccination
Indian researchers are using an engineered protein fragment that is tolerant of high temperatures
Pfizer’s COVID-19 vaccine becomes first to get emergency authorisation
UK government gives nod on basis of interim results, vaccine to be made available by next week
COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet
The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK